Eclipsebio to Present Data and Unveil Antibody Barcode CLIP
Data selected for an oral presentation demonstrates the multiplex ability of Antibody Barcode CLIP to perform transcriptome-wide interrogation of binding sites between RNA and RNA...
Tag : genomics
Dynamoid secures NIH funding to bring science to the metaverse
Dynamoid announced today that it has been awarded a grant from the National Institutes of Health to expand 10k, its VR data visualization platform. 10k transforms the way datasets...
Alithea Genomics Raises CHF 1 Million in Seed Financing Round
Proceeds to Enable Commercialization and Scale-Up of Unique RNA Sequencing Technology Alithea Genomics, a fast-growing, emerging leader in the field of RNA sequencing and transcriptomics...
Data at 2022 ASCO Annual Meeting Highlight Genentech’s Innovation
Pivotal data on glofitamab, a potential first-in-class CD20xCD3 T-cell engaging bispecific antibody in heavily pre-treated patients with aggressive lymphoma, will be presented as part of...
Genomic Vision Announces the Approval by Its Shareholders’ Meeting
Genomic Vision(FR0011799907 – GV – the “Company”), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the...
Element Biosciences Appoints Dr Aitkenhead as Chief Commercial Officer
Dr. Aitkenhead brings 20 years of international commercial experience in the clinical and life science research industry to drive Element’s commercial efforts. Element Biosciences Inc.,...
Genomic Vision Announces Signing Addendum to Contract with Winance
This addendum alters the formula for calculating the number of shares liable to result from the exercise of the equity warrants (BSA) that will be...
LetsGetChecked Expands 360-Degree Care Offering
Leading healthcare solutions company unveils Virtual Consultation functionality to advance mission to empower people with the information and care to live longer, happier lives LetsGetChecked,...
Cell Based Assay & High Content Screening Global Market Outlook
The “Cell Based Assay & High Content Screening Markets 2022 to 2026: Forecasts by User and Product. With Executive and Consultant Guides. including Customized Forecasting and Analysis....
OriCiro Genomics expand into Boston, Open office in North America
OriCiro Genomics K.K. a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapeutics and synthetic biology, today announced the open US...